Heart transplantation is done as a treatment for end-stage heart failure—heart disease that is severe enough that it will lead to death without the new organ. On average, an adult patient who receives a donated heart lives an additional 10 years after surgery. There are many heart conditions that can become severe enough to warrant a heart transplant, such as cardiomyopathy , heart failure, and restrictive myopathy. Some are present at birth and others develop over time e. Some conditions are the result of an injury to the heart, such as a heart attack that damages the heart muscle. Regardless of how the disease process started, you may need a heart transplant if you experience:.
Predictors of hospital length of stay after heart transplantation
Treating Depression After Heart Transplantation - Palliative Care Network of Wisconsin
To reach that conclusion, researchers analyzed the outcomes of nearly 23, adults, aged 18 to 80, who had a heart transplant in the United States between and But the risk of death was two times higher among Black patients aged 18 to 30 and 1. Among the youngest Black patients, the risk of death was greatest during the first year after transplant, with a nearly 2. After age 61, there was no significant racial disparity in outcomes among heart transplantation recipients. Previous research has shown that Black heart transplant patients have a higher risk of death than non-Black recipients, but this is the first study to find that younger Black transplant recipients have a higher risk of death in the first year after their operation.
This is my first post to this site after joining in April of I had a heart transplant in May of , and am doing quite well in all respects. I've tried to research a particular topic on the web, but found very little detailed information, so I am asking members of TransplantFriends. My question relates to sex after a heart transplant - specifically oral sex.
Treating COVID in solid organ transplant SOT , hematopoietic cell transplant HCT , and cellular immunotherapy recipients can be challenging due to the presence of coexisting medical conditions, transplant-related cytopenias, and the need for chronic immunosuppressive therapy to prevent graft rejection and graft-versus-host disease. Transplant recipients may also potentially have increased exposure to severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 given their frequent contact with the health care system. Some transplant recipients have medical comorbidities that have been associated with more severe cases of COVID and a greater risk of mortality, which makes the attributable impact of transplantation on disease severity difficult to assess. The medications that are used to treat COVID may present different risks and benefits to transplant patients and nontransplant patients.